임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
18건 표시
- 1/2상모집 예정· Myeloma MultipleEtenta-Isa-VRd in Newly Diagnosed High-Risk Multiple Myeloma
협력: 애브비, 사노피
- 1/2상모집 중· Relapse Multiple MyelomaStudy of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
협력: 사노피
- 1/2상모집 중· Advanced Solid TumorA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
협력: 사노피
- 1/2상모집 중· Chlamydia Trachomatis ImmunizationPhase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 Years
리드: 사노피
- 1/2상모집 중단 (진행 중)· Neovascular Age-related Macular DegenerationA Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration
리드: 사노피
- 1/2상모집 중단 (진행 중)· Human Metapneumovirus ImmunizationStudy of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
리드: 사노피
- 1/2상모집 중단 (진행 중)· Meningococcal ImmunizationSafety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants
리드: 사노피
- 1/2상모집 중· Plasma Cell Myeloma RefractoryIsatuximab in Combination With Novel Agents in RRMM - Master Protocol
리드: 사노피
- 1/2상모집 중단 (진행 중)· Urothelial Carcinoma of the Urinary BladderIntravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
협력: 사노피
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.